Takeaways from Veeva's R&D and Quality North America Summit
Oct 19, 2023
auto_awesome
Jim Reilly, Veeva's VP of Development Cloud Strategy, joins Richard Young to discuss their takeaways from Veeva's recent North American R&D and Quality Summit. They talk about patient centricity, the future of digital trials, and major updates from Veeva announced at the event.
Patient centricity is a key focus in digital clinical trials and is driving industry progress.
Veeva is committed to improving operational efficiency and standardizing the trial process through their technology solutions.
Deep dives
The mission and values of Viva and its impact on the industry
Viva's mission is to bring a new way of working with technology to improve the life sciences industry. Their values include doing the right thing, delivering what they promise, and acting with speed. The focus on customer success is evident in how Viva showcases industry progress and allows customers to share their experiences and advancements. The annual Summit event highlights the industry's improvement and the importance of collaborative discussions.
Highlights from the Summit and transformation in the industry
The Summit provided a platform for executives to engage in healthy tension discussions, challenging each other on topical issues like patient engagement, research site optimization, and leveraging technology to drive outcomes. Penny from Takeda shared their journey to change the way they operate in clinical trials, emphasizing the importance of Viva's role as part of the larger transformation. The event also showcased Viva's product roadmap sessions, demonstrating their commitment to continuous improvement and delivering high-quality products.
The future of clinical trials and Viva's contributions
The industry's focus is on matching scientific advancements with operational excellence. Viva aims to improve operational efficiency in clinical research, simplifying and standardizing the trial process. They focus on addressing the challenges faced by research sites, such as multiple systems and lack of budget for advanced technology. Viva's commitment to public benefit corporation status aligns with their goal of making good technology accessible and driving the standardization of clinical trials.
Host: Richard Young, VP, Strategy, Veeva Vault CDMS
Guest: Jim Reilly, VP, Development Cloud Strategy, Veeva
This week, Richard Young is joined by Jim Reilly, Veeva’s VP of Development Cloud Strategy. They discuss learnings from Veeva’s recent North American R&D and Quality Summit — including observations and trends from hundreds of biopharmas. Tune in to hear their takeaways on patient centricity, the future of digital trials, and major updates from Veeva announced at the event.
Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.